Evidence map›Paper›PMID 22982594›Full record

ArticleBrain research2012

PPARδ agonist GW501516 prevents uncoupling of endothelial nitric oxide synthase in cerebral microvessels of hph-1 mice.

Anantha Vijay R Santhanam, Livius V d'Uscio, Tongrong He, Zvonimir S Katusic

Abstract read
In one paragraph

Article in Brain research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Role of prostacyclin signaling in endothelial production of soluble amyloid precursor protein-α in cerebral microvessels.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2017
    Article
  4. Review
  5. Article
  6. Article
  7. The COP9 signalosome and vascular function: intriguing possibilities?American journal of cardiovascular disease · 2015
    Review
  8. Article
  9. Article
  10. Mechanisms of vascular dysfunction in mice with endothelium-specific deletion of the PPAR-δ gene.American journal of physiology. Heart and circulatory physiology · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Anantha Vijay R SanthanamDepartment of Anesthesiology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Livius V d'Uscio
Tongrong He
Zvonimir S Katusic
Mayo Clinic · US

Funding

TETRAHYDROBIOPTERIN--REGULATOR OF ENDOTHELIAL FUNCTIONR01HL053524 · NHLBI · MAYO CLINIC ROCHESTER · PI KATUSIC, ZVONIMIR S · 1995 to 2009
$2.3M
Endothelial Dysfunction In The Cerebral CirculationR01HL111062 · NHLBI · MAYO CLINIC ROCHESTER · PI KATUSIC, ZVONIMIR S · 2012 to 2016
$2.3M
Mechanisms of endothelial repair after vascular injuryR01HL091867 · NHLBI · MAYO CLINIC ROCHESTER · PI KATUSIC, ZVONIMIR S · 2009 to 2012
$1.5M
NHLBI NIH HHS HL111062NHLBI NIH HHS HL53524NHLBI NIH HHS HL91867NHLBI NIH HHS R01 HL053524NHLBI NIH HHS R01 HL091867NHLBI NIH HHS R01 HL111062
6 · The paper itself

Abstract

Peroxisome proliferator-activated receptor delta (PPARδ) is ubiquitously expressed in the vasculature, including cerebral circulation. The role of PPARδ in metabolism of tetrahydrobiopterin (BH₄) has not been studied in the cerebral microvasculature. In the present study, the effects of PPARδ agonist GW501516 on uncoupling of endothelial nitric oxide synthase (eNOS) were determined in cerebral microvessels of BH₄-deficient hph-1 mice. Wild-type (B6CBA) and hph-1 mice were orally gavaged with a selective PPARδ activator, GW501516 (2 mg/kg/day) for 14 days, and thereafter, cerebral microvessels were isolated and studied. Treatment of hph-1 mice with GW501516 significantly reduced oxidation of BH₄ and increased the ratio of BH₄ to 7,8-BH₂ (P<0.05, n=6-9). Attenuation of L-NAME-inhibitable superoxide anion levels by GW501516 demonstrated that activation of PPARδ might prevent uncoupling of endothelial nitric oxide synthase (eNOS, P<0.05, n=6-9). Western blotting studies demonstrated that GW501516 selectively increased the endothelial expressions of CuZn superoxide dismutase (P<0.05, n=6-9) and catalase (P<0.05, n=6-8). PPARδ activation increased the total nitrite and nitrate (NO₂+NO₃) content in cerebral microvessels (P<0.05, n=6). Obtained results suggest that in vivo activation of PPARδ prevents eNOS uncoupling, restores bioavailability of NO and may help preserve endothelial function in the BH₄-deficient cerebral circulation.

Indexed as

Analysis of VarianceAnimalsBiopterinsBlood PressureCerebral CortexEnzyme InhibitorsGene Expression Regulation, EnzymologicGTP CyclohydrolaseIn Vitro TechniquesMiceMice, Inbred BALB CMice, TransgenicMicrovesselsMutationNG-Nitroarginine Methyl EsterNitric Oxide Synthase Type IIIBiopterinsEnzyme InhibitorsGTP CyclohydrolaseGW 501516NG-Nitroarginine Methyl EsterNitric Oxide Synthase Type IIIPhc1 protein, mousePolycomb Repressive Complex 1PPAR deltasapropterinSuperoxidesThiazoles

Identifiers

PMID22982594
PMCPMC3474319
OpenAlexW2162211931

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.